For instance, Europe is expected to grow significantly in the GLP-1 receptor agonist market during the forecast period, due to the growing diabetes burden
Adverse events included gastrointestinal effects (e.g., nausea, vomiting, abdominal pain), fainting, headache, migraine, dehydration, acute pancreatitis and gallstones
Potential direct anti-inflammatory mechanisms from preclinical and early clinical studies include: Modulation of immune cell function : GLP-1 receptor activation may reduce pro-inflammatory cytokine production from macrophages and other immune cells Reduction of oxidative stress : These medications may decrease reactive oxygen species production, which contributes to inflammatory processes Endothelial protection : GLP-1 receptor agonists may improve endothelial function and reduce vascular inflammation Inhibition of inflammatory signalling pathways : Including suppression of nuclear factor-kappa B (NF-B), a key regulator of inflammatory gene expression It's important to note that many of these mechanisms have been primarily demonstrated in laboratory or animal studies, with more limited evidence in humans
What it means is that medicine is humbling
From a clinical perspective, the right time for reflux repair in patients with medication-induced or medication-worsened reflux is when conservative measures, such as drug therapy and lifestyle changes, fail to provide clear and significant symptom relief
Educational Disclaimer These statements have not been evaluated by the Food and Drug Administration